Jones Financial Companies
BNGO icon

Jones Financial Companies’s Bionano Genomics BNGO Stock Holding History

Jones Financial Companies’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2
Closed -$3 – 4422
2025
Q3 		$3 Hold
2
– – ﹤0.01% 4218
2025
Q2 		$7 Hold
2
– – ﹤0.01% 4015
2025
Q1 		$6 Sell
2
-1
-33% -$7 ﹤0.01% 3692
2024
Q4 		$53 Hold
3
– – ﹤0.01% 3378
2024
Q3 		$83 Buy
+3
New +$93 ﹤0.01% 2978

Other funds holding BNGO

GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CAM
Carret Asset Management New York $1.14B AUM 35.33% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
RS
R Squared Central, Hong Kong $190M AUM 25.89% 1-Year Est. Return

Jones Financial Companies's BNGO Position: Q4 2025 in Review

Jones Financial Companies sold out of Bionano Genomics (BNGO) in Q4 2025, closing a stake of 2 shares — an estimated $3 sold.

Jones Financial Companies first reported a position in BNGO in Q3 2024 and held it in 5 quarters. The position peaked at $83 in Q3 2024. 32 funds tracked by Wall St. Rank hold BNGO as of Q4 2025.

  • Jones Financial Companies reported no remaining Bionano Genomics position as of Q4 2025 after selling out during the quarter.
  • Jones Financial Companies sold 2 Bionano Genomics shares in Q4 2025, an estimated $3.
  • Jones Financial Companies first reported a position in Bionano Genomics in Q3 2024 and held it in 5 quarters.
  • Jones Financial Companies's Bionano Genomics position peaked at $83 in Q3 2024.
  • 32 funds tracked by Wall St. Rank held Bionano Genomics as of Q4 2025.

Based on Jones Financial Companies's 13F filing for Q4 2025, filed 17 Feb 2026.